Patent Yard Sign in
Canadian application, no grantCanada

Benzenesulfonyl(thio)ureas for the treatment of septic shock and sirs

CA 2450002 A1 · Owner: Wirth, Klaus · Inventors: Gerlach, Uwe; Wirth, Klaus; Englert, Heinrich Christian

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention relates to the use of substituted benzenesulfonylureas and benzenesulfonylthioureas of the formula (I) in which R1, R2, E, X, Y and , Z have the meanings given in the claims for treating pathological changes in , blood pressure associated with the disease patterns of septic shock and generalized inflammatory syndrome, and to their use for producing medicaments for this purpose.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed June 13, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 13, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 13, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 13, 2002
GrantedNo grant recorded
Term endedJune 13, 2022
Patent numberCA 2450002 A1
Classification (IPC)A61K31/17 +2 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedJune 13, 2002Term endedJune 13, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.